CMRX $2.10 in cash and no debt / enough to sustain through 2026 smart investors / Insiders are buying as well / year end tax loss harvesting is almost done and I believe biotechs will run fast in jan / feb
−0.9267USD
−82.10 MUSD
324.00 KUSD
79.36 M
About Chimerix, Inc.
Sector
CEO
Michael T. Andriole
Headquarters
Durham
Website
Employees (FY)
72
Founded
2000
ISIN
US16934W1062
FIGI
BBG000R33651
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
CMRX waiting for news Now we just need some news to get dropped. Some positive ones, and we are ready to do.
target 2.90 ( 1 to 5 months )Good Technical ( Nice Breakout ) and Good Fundamental ( Good Result ) , So Target 2.90 , Duration 1 to 5 months.
Chimerix Awarded BARDA Contract for TEMBEXACMRX: Chimerix, Inc.
2022-08-29 10:45:00 Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
Chimerix Announces Positive Topline Results for ONC201 in RecurrCMRX: Chimerix, Inc.
2021-11-04 07:00:00
Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma
CMRX 2/7/2020Analysis-
Daily chart- After long downtrend, price has been in sideways market between 1.24-3.38 for 638 days. After making a move to resistance on July2020, price fell and found support from 200 MA then working itself back to resistance and finally breaking out. After breakout of 40%, price pulled
CMRX descending wedge formedsimple wedge formed in order to add onto my long term hold once we hopefully bounce off of the 3.26 fib level
CMRX daily 160% gains setup(STOCKS)before we kick start the update. your upvotes/subs are appreciated.
Why get subbed to to me on Tradingview?
-15+ years real live trading experience
-TOP Author on TradingView
-professional chart break downs
-key levels
-no junk on my charts
-frequent updates
-covering FX/crypto/US stocks
-24/7
$CMRX Chimerix Inc Moving big pore market - Covid-19DURHAM, N.C., April 29, 2020 (GLOBE NEWSWIRE) -- Chimerix (CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the Company’s initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19 patie
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CMRX is 0.9040 USD — it has decreased by 1.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Chimerix, Inc. stocks are traded under the ticker CMRX.
Chimerix, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CMRX stock is 4.25% volatile and has beta coefficient of 0.81. Check out the list of the most volatile stocks — is Chimerix, Inc. there?
One year price forecast for Chimerix, Inc. has a max estimate of 11.0000 USD and a min estimate of 5.0000 USD.
CMRX earnings for the last quarter are −0.27 USD whereas the estimation was −0.23 USD which accounts for −18.13% surprise. Estimated earnings for the next quarter are −0.24 USD. See more details about Chimerix, Inc. earnings.
Chimerix, Inc. revenue for the last quarter amounts to 11.00 K USD despite the estimated figure of 89.17 K USD. In the next quarter revenue is expected to reach 82.00 K USD.
Yes, you can track Chimerix, Inc. financials in yearly and quarterly reports right on TradingView.
CMRX stock has fallen by 8.69% compared to the previous week, the month change is a 22.07% fall, over the last year Chimerix, Inc. has showed a 27.68% decrease.
CMRX net income for the last quarter is −18.16 M USD, while the quarter before that showed −23.99 M USD of net income which accounts for 24.28% change. Track more Chimerix, Inc. financial stats to get the full picture.
Today Chimerix, Inc. has the market capitalization of 80.65 M, it has decreased by 0.99% over the last week.
No, CMRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CMRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Chimerix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 72.00 employees. See our rating of the largest employees — is Chimerix, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Chimerix, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Chimerix, Inc. stock shows the sell signal. See more of Chimerix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Chimerix, Inc. future price: according to them, CMRX price has a max estimate of 11.00 USD and a min estimate of 5.00 USD. Read a more detailed Chimerix, Inc. forecast: see what analysts think of Chimerix, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Chimerix, Inc. EBITDA is −93.06 M USD, and current EBITDA margin is −28.72 K%. See more stats in Chimerix, Inc. financial statements.